|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities available-for-sale ("AFS") | ||||||||||||||||||||
| Securities available-for-sale ("AFS"), at fair value (amortized cost of $2,426,995 and $1,335,225 at December 31, 2025 and December 31, 2024 respectively; net of allowance for credit losses of $557 and $4,134 at December 31, 2025 and December 31, 2024 respectively) | ||||||||||||||||||||
| Securities held-to-maturity ("HTM") (fair value of $587,289 and $636,840 at December 31, 2025 and December 31, 2024, respectively) | ||||||||||||||||||||
| Allowance for credit losses - investments | ||||||||||||||||||||
| Net securities | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans held for sale ("LHFS") | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||||||
| Total loans held for investment, net | ||||||||||||||||||||
| Investment in Federal Home Loan Bank ("FHLB") stock | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred taxes, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Real estate owned ("REO") | ||||||||||||||||||||
| Goodwill and intangibles | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Core deposit intangibles | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Subordinated debt | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 29,521 shares issued and outstanding at December 31, 2025 and 29,811 shares issued and outstanding at December 31, 2024 | ||||||||||||||||||||
| Common stock, $0.001 par value; 200,000,000 shares authorized at December 31, 2025 and December 31, 2024; 82,884,401 shares and 82,365,388 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Retained (deficit) earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
Loading...
